TC
RIGL icon

Truvestments Capital’s Rigel Pharmaceuticals RIGL Stock Holding History

Truvestments Capital’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.4K Buy
2,387
+180
+8% +$5.55K 0.01% 417
2026
Q1 		$59.7K Hold
2,207
– – 0.01% 474
2025
Q4 		$94.5K Buy
2,207
+1,205
+120% +$45.4K 0.02% 347
2025
Q3 		$28.4K Buy
1,002
+125
+14% +$3.74K 0.01% 531
2025
Q2 		$16.4K Buy
+877
New +$16.6K ﹤0.01% 572

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truvestments Capital's RIGL Position: Q2 2026 in Review

Truvestments Capital increased its Rigel Pharmaceuticals (RIGL) stake by 8.2% in Q2 2026, buying an estimated $5.55K and bringing the position to 2,387 shares worth $93.4K. The position accounts for 0.01% of the portfolio, ranked #417.

Truvestments Capital first reported a position in RIGL in Q2 2025 and has held it in 5 quarters since. The position peaked at $94.5K in Q4 2025. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Truvestments Capital held 2,387 shares of Rigel Pharmaceuticals worth $93.4K as of Q2 2026.
  • Truvestments Capital bought 180 Rigel Pharmaceuticals shares in Q2 2026, an estimated $5.55K.
  • Rigel Pharmaceuticals made up 0.01% of Truvestments Capital's portfolio in Q2 2026, its #417 holding.
  • Truvestments Capital first reported a position in Rigel Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Truvestments Capital's Rigel Pharmaceuticals position peaked at $94.5K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.